Biktarvy, formally known as bictegravir, is a potent single-tablet regimen for controlling HIV infection. This formula combines three crucial antiviral drugs: bictegravir, emtricitabine, and tenofovir alafenamide. It functions by preventing the the viral ability to multiply within the body, remarkably lowering the viral burden. For many individua